SPOTLIGHT -
New treatments for obesity and OAB
FDA approves Lorcaserin and Mirabegron extended-release tablets.
Pancrelipase DR caps approved for EPI
FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.
FDA approves oral inhibitor for ED
FDA approves avanafil and tafluprost
Lucinactant approved for premie RDS
FDA approves Lucinactant and Peginesatide
